Ganga Pharmaceuticals Complete Financial Statements
GANGAPHARM • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Ganga Pharmaceuticals (GANGAPHARM).
Downloads include all available records across all periods.
For market performance, see the
GANGAPHARM stock price today
.
Profitability Ratios
Operating Margin
-4.00%
2025 data
Balance Sheet Ratios
Debt to Equity
1.29
2025 data
Equity Ratio
77.78%
2025 data
Asset Turnover
0.33
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-33.3%
Year-over-Year
Expense Growth
-66.7%
Year-over-Year
Financing Cash Flow Growth
-100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 |
| Expenses | 1 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 2 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Operating Profit Margin % | -2.00% | -4.00% | 2.00% | 0.00% | 2.00% | 1.00% | 13.00% | 12.00% | 11.00% | 10.00% | 12.00% | 9.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.10 | 0.16 | 0.11 | 0.10 | 0.09 | 0.05 | 0.46 | 0.46 | 0.23 | 0.18 | 0.12 | 0.00 |
Related Pages for Ganga Pharmaceuticals
Additional stock information and data for GANGAPHARM
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 5 |
| Current Assets | 7 | 6 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 5 | 2 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 5 |
| LIABILITIES | |||||||||||
| Total Liabilities | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 5 |
| Current Liabilities | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 7 | 7 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 3 |
| Share Capital | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 |
| Reserves & Surplus | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Investing Activities | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 0 |
| Financing Activities | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |